Meconium drug screening of stillborn infants: A feasibility study

Fetal Diagnosis and Therapy

Volumn 12, Issue 4, 1997, Pages 248-251

  Lauria, Michele R ^a   Qureshi, Faisal ^a   Jacques, Suzanne M ^a   Kurtzhals, Pamela ^a   Ostrea, Enrique M ^b   Gonik, Bernard ^a   Sorokin, Yoram ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Drug screening; Fetus; Meconium; Stillbirth

Indexed keywords

COCAINE; OPIATE;

ADOLESCENT; ADULT; ARTICLE; DRUG ABUSE; DRUG SCREENING; FEMALE; FETUS; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MECONIUM; MOTHER; NORMAL HUMAN; PRIORITY JOURNAL; STILLBIRTH;

EID: 0030931853     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264478     Document Type: Article

References (32)

1. Bingol N, Fuchs M, Daiz V, Stone RK, Gromisch DS: Teratogenicity of cocaine in humans. J Pediatr 1987:110:93-96.
2. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA: Cocaine use in pregnancy. N Engl J Med 1985; 313:666-669.
3. Khalsa JH, Gfroerer J: Epidemiology and health consequences of drug abuse among pregnant women: A large-scale, prospective, epidemiologic study. Semin Perinatol 1991; 15:265-270.
4. MacGregor SN, Keith LG, Chasnoff IJ, Rosner MA, Chisum GM, Shaw P, Minogue JP: Cocaine use during pregnancy: Adverse perinatal outcome. Am J Obstet Gynecol 1987; 157:686-690.
5. Oro AS, Dixon SD: Perinatal cocaine and mc-thamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987,111:571-578.
6. Ostrea EM, Chavez CS: Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: a study of 830 cases. J Pediatr 1979;94:292-295.
7. Rosengren SS, Longobucco DB, Bernstein BA, Fishman S, Cooke E, Boctor F, Lewis SC: Meconium testing for cocaine metabolites: Prevalence, perceptions, and pitfalls. Am J Obstet Gynecol 1993;168:1449-1456.
8. Buchi KF, Varner MW, Chase RA: The prevalence of substance abuse among pregnant women in Utah. Obstet Gynecol 1993;81:239-242.
9. Burke MS, Roth D: Anonymous cocaine screening in a private obstetric population. Obstet Gynecol 1993;81:354-356.
10. Chasnoff IJ: Drug use and women: establishing a standard of care. Ann NY Acad Sci 1989;562: 208-210.
11. Christmas JT, Knisely JS, Dawson KS, Dins-moor MJ, Weber SE, Schnoll SH: Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstet Gynecol 1992;80:750-754.
12. Crespo JMM, Antolin E, Comas C, Coll O, Marques JM, Gual A, Fortuny A: The prevalence of cocaine abuse during pregnancy in Barcelona. Eur J Obstet Gynecol Reprod Biol 1994;56:165-167.
13. McCalla S, Minkoff HL, Feldman J, Glass L, Valencia G: Predictors of cocaine use in pregnancy. Obstet Gynecol 1992;79:641-644.
14. Ostrea EM, Brady M, Gause S, Raymundo AL, Stevens M: Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study. Pediatrics 1992:89:107-113.
15. Ostrca EM, Romero A, Yee H: Adaptation of the meconium drug test for mass screening. J Pediatr 1993;122:152-154.
16. Ryan RM, Wagner CL, Schultz JM, Varley J, DiPreta J, Sherer DM, Phelps DL, Kwong T: Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr 1994;125:435-440.
17. Sloan LB, Gay JW, Snyder SW, Bales SR: Substance abuse during pregnancy in a rural population. Obstet Gynecol 1992;79:245-248.
18. Vaughn AJ, Carzoli RP, Sanchez-Ramos L, Murphy S, Khan N, Chiu T: Community-wide estimation of illicit drug use in delivering women: Prevalence, demographics, and associated risk factors. Obstet Gynecol 1993;82:92-96.
19. Vega WA, Dolody B, Hwang J, Noble A: Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993;329: 850-854.
20. Bandstra E, Steele B, Chitwood D, Wu N, Coyne T, Freier MC, Bean JA, Oei J, Burkett G, Hirne GW, Hearn WL: Detection of in utero cocaine exposure: A comparative methodologic study. PrcdiatrRes 1992;31:58A.
21. Callahan CM, Grant TM, Phipps BS, Clark G, Novack AH, Streissguth AP, Raisys VA: Measurement of gestational cocaine exposure: Sensitivity of newborn hair, meconium and urine. J Pediatr 1992;120:763-768.
22. Ostrca EM, Brady MJ, Parks PM, Asensio DC, Naluz A: Drug screening of meconium in infants of drug dependent mothers: An alternative to urine screening. J Pediatr 1989; 115: 474-477.
23. Maynard ED, Amuroso LP, Oh W: Meconium for drug testing. AJDC 1991; 145:652.
24. Ostrea EM, Knapp DK, Tannenbaum L, Ostrca A, Romero A, Montes N, Saleri V: Serial meconium drug analysis can estimate the chronology and degree of the infant’s in utero drug exposure. Pediatr Res 1993;33:229A.
25. Ostrea EM, Romero A, Knapp K, Ostrea AR, Lucena JE, Utarnachitt RB: Postmortem drug analysis of meconium in early-gestation human fetuses exposed to cocaine: Clinical implications. J Pediatr 1994;124:477-479.
26. Montes N, Romero A, Ostrea EM, Ostrea AR: Improved method of GC/MS analysis of meconium for opiate, cocaine, and cannabinoid. Pediatr Res 1993:66A.
27. Lucena J, Silvestrc MA, Raymundo AL, Roxas R Jr, Ostrea EM Jr: The effect of time, dosage duration of cocaine intake during pregnancy on the amount of cocaine in meconium in a rat model. Pediatr Res 1991;29:66A.
28. Ostrea EM, Knapp DK, Romero A, Tannenbaum L, Ostrea AR: How early in gestation drugs are detectable in meconium. Pediatr Res 1993;33:67A.
29. Smith CA: Physiology of the digestive tract; in Smith CA, Nelson NW (eds): The Physiology of the Newborn Infant. Springfield. Thomas, 1976.
30. Ostrea EM, Martier S, Welch R, Brady M: Sensitivity of meconium drug screen in detecting intrauterine drug exposure of infants. Pediatr Res 1990; 17:1022A.
31. Bailey DN: Drug screening in an unconventional matrix: Hair analysis. JAMA 1989;262: 3331.
32. Graham K, Koren G, Klein J, Schneiderman J, Grcenwald M: Determination of gestational cocaine exposure by hair analysis. JAMA 1989; 262:3328-3330.